Behavioral Abnormalities, Cognitive Impairments, Synaptic Deficits, and Gene Replacement Therapy in a CRISPR Engineered Rat Model of 5p15.2 Deletion Associated With Cri du Chat Syndrome
Open Access
- 18 February 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (14) , e2415224
Abstract
The Cri du Chat Syndrome (CdCS), a devastating genetic disorder caused by a deletion on chromosome 5p, faces challenges in finding effective treatments and accurate animal models. Using CRISPR‐Cas9, a novel CdCS rat model with a 2q22 deletion is developed, mirroring a common genetic alteration in CdCS patients. This model exhibits pronounced deficits in social behavior, cognition, and anxiety, accompanied by neuronal abnormalities and immune dysregulation in key brain regions such as the hippocampus and medial prefrontal cortex (mPFC). The immunostaining and RNA‐seq analyses provide new insights into CdCS pathogenesis, revealing inflammatory and immune processes. Importantly, it is demonstrated that early gene replacement therapy with AAV‐ Ctnnd2 alleviates cognitive impairments in CdCS rats, highlighting the potential for early intervention. However, the effectiveness of this therapy is confined to the early developmental stages and does not fully restore all CdCS symptoms. The findings deepen the understanding of CdCS pathogenesis and suggest promising therapeutic directions.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (L222077, IS23097)
This publication has 143 references indexed in Scilit:
- Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer TherapyAdvanced Materials, 2023
- GABRG1 variant as a potential novel cause of epileptic encephalopathy, hypotonia, and global developmental delayAmerican Journal of Medical Genetics Part A, 2022
- Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaAdvanced Science, 2021
- A child with autism, behavioral issues, and dysmorphic features found to have a tandem duplication within CTNND2 by mate‐pair sequencingAmerican Journal of Medical Genetics Part A, 2019
- Inflammatory Biomarkers and Risk of SchizophreniaJAMA Psychiatry, 2017
- Role of Wnt5a in the Pathogenesis of Inflammatory DiseasesJournal of Cellular Physiology, 2016
- Amelioration of the typical cognitive phenotype in a patient with the 5pter deletion associated with Cri‐du‐chat syndrome in addition to a partial duplication of CTNND2American Journal of Medical Genetics Part A, 2014
- Growth charts for cri‐du‐chat syndrome: An international collaborative studyAmerican Journal of Medical Genetics, 2000
- ?-catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during developmentJournal of Comparative Neurology, 2000
- Nerve growth factor: two receptors, multiple functionsBioEssays, 1998